Published in Urology on October 01, 2000
Low-Fat Fish Oil Diet for Prostate Cancer Prevention | NCT00798876
Prostate cancer and inflammation: the evidence. Histopathology (2012) 2.60
COX-2 expression predicts prostate-cancer outcome: analysis of data from the RTOG 92-02 trial. Lancet Oncol (2007) 1.95
Autocrine/paracrine prostaglandin E2 production by non-small cell lung cancer cells regulates matrix metalloproteinase-2 and CD44 in cyclooxygenase-2-dependent invasion. J Biol Chem (2002) 1.60
COX-2 expression is associated with an aggressive phenotype in ductal carcinoma in situ. Br J Cancer (2004) 1.59
Effect of altering dietary omega-6/omega-3 fatty acid ratios on prostate cancer membrane composition, cyclooxygenase-2, and prostaglandin E2. Clin Cancer Res (2006) 1.50
Non-small cell lung cancer cyclooxygenase-2-dependent invasion is mediated by CD44. J Biol Chem (2001) 1.36
Cyclooxygenases in hepatocellular carcinoma. World J Gastroenterol (2006) 1.31
Antagonists of growth hormone-releasing hormone (GHRH) reduce prostate size in experimental benign prostatic hyperplasia. Proc Natl Acad Sci U S A (2011) 1.21
Cyclooxygenase-1 is up-regulated in cervical carcinomas: autocrine/paracrine regulation of cyclooxygenase-2, prostaglandin e receptors, and angiogenic factors by cyclooxygenase-1. Cancer Res (2002) 1.20
Cyclooxygenase in normal human tissues--is COX-1 really a constitutive isoform, and COX-2 an inducible isoform? J Cell Mol Med (2008) 1.18
TGF-β effects on prostate cancer cell migration and invasion are mediated by PGE2 through activation of PI3K/AKT/mTOR pathway. Endocrinology (2013) 1.16
COX2 genetic variation, NSAIDs, and advanced prostate cancer risk. Br J Cancer (2007) 1.11
Nonsteroidal anti-inflammatory drugs and prostate cancer: a systematic review of the literature and meta-analysis. Can Urol Assoc J (2009) 1.07
Red meat and poultry, cooking practices, genetic susceptibility and risk of prostate cancer: results from a multiethnic case-control study. Carcinogenesis (2012) 1.06
COX-2 and cancer: a new approach to an old problem. Br J Pharmacol (2001) 1.02
Regulation of Cox-2 by cyclic AMP response element binding protein in prostate cancer: potential role for nexrutine. Neoplasia (2007) 1.01
Requirement of cyclooxygenase-2 expression and prostaglandins for human prostate cancer cell invasion. Clin Exp Metastasis (2002) 1.01
Association of the innate immunity and inflammation pathway with advanced prostate cancer risk. PLoS One (2012) 1.01
Differential expression of thromboxane synthase in prostate carcinoma: role in tumor cell motility. Am J Pathol (2004) 1.00
Polymorphisms in carcinogen metabolism enzymes, fish intake, and risk of prostate cancer. Carcinogenesis (2012) 0.99
Atorvastatin and celecoxib in combination inhibits the progression of androgen-dependent LNCaP xenograft prostate tumors to androgen independence. Cancer Prev Res (Phila) (2010) 0.98
Celecoxib and GABA cooperatively prevent the progression of pancreatic cancer in vitro and in xenograft models of stress-free and stress-exposed mice. PLoS One (2012) 0.97
Prostaglandin E2 and F2alpha activate the FP receptor and up-regulate cyclooxygenase-2 expression via the cyclic AMP response element. Mol Cell Endocrinol (2008) 0.94
Flurbiprofen alone and in combination with alfuzosin for the management of lower urinary tract symptoms. Cent European J Urol (2015) 0.94
Nonsteroidal anti-inflammatory drugs and prostatic diseases. Biomed Res Int (2014) 0.91
Effects of flavocoxid, a dual inhibitor of COX and 5-lipoxygenase enzymes, on benign prostatic hyperplasia. Br J Pharmacol (2012) 0.91
Association between COX-2 rs2745557 polymorphism and prostate cancer risk: a systematic review and meta-analysis. BMC Immunol (2012) 0.89
Benzo-[a]-pyrene increases invasion in MDA-MB-231 breast cancer cells via increased COX-II expression and prostaglandin E2 (PGE2) output. Clin Exp Metastasis (2005) 0.89
Ciglitazone mediates COX-2 dependent suppression of PGE2 in human non-small cell lung cancer cells. Prostaglandins Leukot Essent Fatty Acids (2007) 0.86
Cyclooxygenase-2 overexpression in chronic inflammation associated with benign prostatic hyperplasia: is it related to apoptosis and angiogenesis of prostate cancer? Korean J Urol (2011) 0.84
Cyclooxygenase-2 expression as a predictor of outcome in colorectal carcinoma. World J Gastroenterol (2012) 0.84
The target of arachidonic acid pathway is a new anticancer strategy for human prostate cancer. Biologics (2008) 0.82
Modulatory effect of silymarin on inflammatory mediators in experimentally induced benign prostatic hyperplasia: emphasis on PTEN, HIF-1α, and NF-κB. Naunyn Schmiedebergs Arch Pharmacol (2014) 0.82
Arachidonic acid metabolism in human prostate cancer. Int J Oncol (2012) 0.82
Antibiotic and anti-inflammatory use and the risk of prostate cancer. BMC Res Notes (2009) 0.81
Stimulation of epithelial CB1 receptors inhibits contractions of the rat prostate gland. Br J Pharmacol (2006) 0.81
Design of Fluorine-Containing 3,4-Diarylfuran-2(5H)-ones as Selective COX-1 Inhibitors. ACS Med Chem Lett (2014) 0.78
Vitamin D and Immune Response: Implications for Prostate Cancer in African Americans. Front Immunol (2016) 0.78
Nutrigenomics: a case for the common soil between cardiovascular disease and cancer. Genes Nutr (2008) 0.78
Regulation of the prostaglandin pathway during development of invasive bladder cancer in mice. Prostaglandins Other Lipid Mediat (2008) 0.78
Inhibition of prostaglandin synthesis and actions contributes to the beneficial effects of calcitriol in prostate cancer. Dermatoendocrinol (2009) 0.77
PET radiotracer [¹⁸F]-P6 selectively targeting COX-1 as a novel biomarker in ovarian cancer: preliminary investigation. Eur J Med Chem (2014) 0.77
Quantitative immunohistochemical detection of the molecular expression patterns in proliferative inflammatory atrophy. J Mol Histol (2006) 0.77
Association between polymorphisms in selected inflammatory response genes and the risk of prostate cancer. Onco Targets Ther (2016) 0.76
Quantification of Arachidonic Acid and Its Metabolites in Rat Tissues by UHPLC-MS/MS: Application for the Identification of Potential Biomarkers of Benign Prostatic Hyperplasia. PLoS One (2016) 0.75
Management of Benign Prostatic Hyperplasia: Could Dietary Polyphenols Be an Alternative to Existing Therapies? Front Pharmacol (2017) 0.75
Association of COX-2 Promoter Polymorphisms -765G/C and -1195A/G with Migraine. Iran J Public Health (2016) 0.75
Non-Steroidal Anti-Inflammatory Drugs, Variation in Inflammatory Genes, and Aggressive Prostate Cancer. Pharmaceuticals (Basel) (2010) 0.75
Saturated fatty acids up-regulate COX-2 expression in prostate epithelial cells via toll-like receptor 4/NF-κB signaling. Inflammation (2014) 0.75
Inhibitory effect of rape pollen supercritical CO2 fluid extract against testosterone-induced benign prostatic hyperplasia in rats. Exp Ther Med (2014) 0.75
Withania coagulans Extract Induces Cell Apoptosis and Inhibits COX-2 Expression in a Rat Model of Benign Prostatic Hyperplasia. Nephrourol Mon (2016) 0.75
Roles of Eicosanoids in Prostate Cancer. Future Lipidol (2008) 0.75
Inhibition of cyclooxygenase-2-mediated matriptase activation contributes to the suppression of prostate cancer cell motility and metastasis. Oncogene (2017) 0.75
Predictive medicine in non-malignant urological disorders. World J Urol (2003) 0.75
Do Aspirin and Other NSAIDs Confer a Survival Benefit in Men Diagnosed with Prostate Cancer? A Pooled Analysis of NIH-AARP and PLCO Cohorts. Cancer Prev Res (Phila) (2017) 0.75
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell (1997) 15.96
Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial. Lancet (1999) 6.69
Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence. Science (1999) 6.37
Guided medication dosing for inpatients with renal insufficiency. JAMA (2001) 6.25
Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis. Ann Neurol (1999) 5.83
Facial fractures and submental tracheal intubation. Anaesthesia (2002) 4.13
The Australian Incident Monitoring Study. Crisis management--validation of an algorithm by analysis of 2000 incident reports. Anaesth Intensive Care (1993) 4.04
An STS-based radiation hybrid map of the human genome. Genome Res (1997) 3.57
Mutation of a gene encoding a protein with extracellular matrix motifs in Usher syndrome type IIa. Science (1998) 2.84
Effect of RF coil excitation on field inhomogeneity at ultra high fields: a field optimized TEM resonator. Magn Reson Imaging (2001) 2.84
Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proc Natl Acad Sci U S A (2000) 2.83
Variable and tissue-specific hormone resistance in heterotrimeric Gs protein alpha-subunit (Gsalpha) knockout mice is due to tissue-specific imprinting of the gsalpha gene. Proc Natl Acad Sci U S A (1998) 2.71
Helios, a T cell-restricted Ikaros family member that quantitatively associates with Ikaros at centromeric heterochromatin. Genes Dev (1998) 2.37
The mouse c-abl locus: molecular cloning and characterization. Cell (1984) 2.33
Clinical intestinal transplantation: new perspectives and immunologic considerations. J Am Coll Surg (1998) 2.31
Adductor tenotomies in children with quadriplegic cerebral palsy: longer term follow-up. J Pediatr Orthop (2000) 2.21
Outcome of liver transplantation in hepatitis C virus-infected patients who received hepatitis C virus-infected grafts. Gastroenterology (1999) 2.19
Mice lacking major histocompatibility complex class I and class II molecules. Proc Natl Acad Sci U S A (1993) 2.18
Pathogenesis of Shiga toxin-induced hemolytic uremic syndrome. Pediatr Nephrol (2001) 2.18
Intensive cataract training: a novel approach. Eye (Lond) (2013) 2.17
N-cadherin regulates target specificity in the Drosophila visual system. Neuron (2001) 2.16
Modification and validation of the Birmingham Vasculitis Activity Score (version 3). Ann Rheum Dis (2008) 2.12
In vivo cytokine gene expression in T cell subsets of the autoimmune MRL/Mp-lpr/lpr mouse. Eur J Immunol (1990) 2.00
NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells. Cancer Res (1998) 2.00
Access to data: comparing AccessMed with Query by Review. J Am Med Inform Assoc (1996) 1.98
Secreted proNGF is a pathophysiological death-inducing ligand after adult CNS injury. Proc Natl Acad Sci U S A (2004) 1.98
The Cox proportional hazards model with change point: an epidemiologic application. Biometrics (1990) 1.95
The hypothalamus and the control of energy homeostasis: different circuits, different purposes. Physiol Behav (2002) 1.89
The role of "indirect" recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice. Proc Natl Acad Sci U S A (1993) 1.86
Structural studies of the Vibrio cholerae O-antigen. Carbohydr Res (1982) 1.78
Retrovirus vector silencing is de novo methylase independent and marked by a repressive histone code. EMBO J (2000) 1.78
Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo. J Urol (2000) 1.78
Genomic structure and identification of novel mutations in usherin, the gene responsible for Usher syndrome type IIa. Am J Hum Genet (2000) 1.76
Cloning and expression of a smooth muscle caldesmon. J Biol Chem (1989) 1.74
Angiopoietin-1 is expressed in the synovium of patients with rheumatoid arthritis and is induced by tumour necrosis factor alpha. Ann Rheum Dis (2003) 1.74
Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. American Academy of Allergy, Asthma, and Immunology. Ann Allergy Asthma Immunol (1998) 1.73
Defining thyrotropin-dependent and -independent steps of thyroid hormone synthesis by using thyrotropin receptor-null mice. Proc Natl Acad Sci U S A (2002) 1.70
Acute airway management in the critically ill child requiring transport. Can J Anaesth (1991) 1.63
Phosphorylation of the RNA polymerase II carboxy-terminal domain by the Bur1 cyclin-dependent kinase. Mol Cell Biol (2001) 1.61
Controlling epidermal growth factor (EGF)-stimulated Ras activation in intact cells by a cell-permeable peptide mimicking phosphorylated EGF receptor. J Biol Chem (1996) 1.61
Dielectric resonances and B(1) field inhomogeneity in UHFMRI: computational analysis and experimental findings. Magn Reson Imaging (2001) 1.60
Carbohydrate metabolism in lactic streptococci: fate of galactose supplied in free or disaccharide form. Appl Microbiol (1973) 1.57
Inpatient emergencies encountered by an infectious disease consultative service. Clin Infect Dis (1998) 1.56
Neuromyelitis optica-IgG in idiopathic inflammatory demyelinating disorders amongst Hong Kong Chinese. Eur J Neurol (2009) 1.54
Colonic polyps in an unselected population: prevalence, characteristics, and associations. Am J Gastroenterol (1994) 1.53
Paternal versus maternal transmission of a stimulatory G-protein alpha subunit knockout produces opposite effects on energy metabolism. J Clin Invest (2000) 1.51
Clinical, histopathological and immunohistochemical assessment of human skin field cancerization before and after photodynamic therapy. Br J Dermatol (2012) 1.49
Medical management of a large aortic thrombus in a young woman with essential thrombocythemia. Mayo Clin Proc (2001) 1.49
Attenuation of ischemic liver injury by monoclonal anti-endothelin antibody, AwETN40. J Am Coll Surg (1997) 1.47
Jugular venous bulb catheterization in infants and children. Crit Care Med (1989) 1.47
A chimeric form of osteoprotegerin inhibits hypercalcemia and bone resorption induced by IL-1beta, TNF-alpha, PTH, PTHrP, and 1, 25(OH)2D3. J Bone Miner Res (1999) 1.47
Prospective analysis of prostate-specific markers in pelvic lymph nodes of patients with high-risk prostate cancer. J Natl Cancer Inst (1997) 1.44
Upregulation of vascular endothelial growth factor by cobalt chloride-simulated hypoxia is mediated by persistent induction of cyclooxygenase-2 in a metastatic human prostate cancer cell line. Clin Exp Metastasis (1999) 1.42
The influence of hepatitis C virus genotypes on the outcome of liver transplantation. Liver Transpl Surg (1998) 1.42
Overdose with chloral hydrate: a pharmacological and therapeutic review. Med J Aust (1989) 1.42
Spectrum of single- and multiexon NF1 copy number changes in a cohort of 1,100 unselected NF1 patients. Genes Chromosomes Cancer (2006) 1.41
Disease management. Decreasing cost and increasing patient satisfaction: the implementation of a cancer disease management program. Manag Care Interface (1999) 1.40
Bioactive and nuclease-resistant L-DNA ligand of vasopressin. Proc Natl Acad Sci U S A (1997) 1.40
Theoretical model for an MRI radio frequency resonator. IEEE Trans Biomed Eng (2000) 1.40
The experience of nausea during sustained hyper-gravity flight with negligible angular velocity. Aviat Space Environ Med (2000) 1.40
UHG-based mutation screening in type 2B von Willebrand's disease: detection of a candidate mutation Ser547Phe. Thromb Haemost (1996) 1.39
Strategies to inhibit alloantibody production in alloprimed murine recipients of hematopoietic stem cell grafts. Am J Transplant (2015) 1.39
Pediatric and neonatal critical care transport: a comparison of therapeutic interventions. Pediatr Emerg Care (1996) 1.39
Cryoablation of ventricular tachycardia guided by return cycle mapping after entrainment. J Thorac Cardiovasc Surg (2001) 1.37
Innexins: a family of invertebrate gap-junction proteins. Trends Genet (1998) 1.36
DNA triple-helix specific intercalators as antigene enhancers: unfused aromatic cations. Biochemistry (1993) 1.34
Preservation of functioning human thyroid organoids in the scid mouse: 1. System characterization. J Clin Endocrinol Metab (1993) 1.33
Relative risk of Alzheimer disease and age-at-onset distributions, based on APOE genotypes among elderly African Americans, Caucasians, and Hispanics in New York City. Am J Hum Genet (1996) 1.30
Isolation and functional comparison of bovine cardiac troponin T isoforms. J Biol Chem (1987) 1.29
Protection of retinal ganglion cells from natural and axotomy-induced cell death in neonatal transgenic mice overexpressing bcl-2. J Neurosci (1996) 1.29
Aromatase-deficient (ArKO) mice accumulate excess adipose tissue. J Steroid Biochem Mol Biol (2001) 1.28
The Src-suppressed C kinase substrate, SSeCKS, is a potential metastasis inhibitor in prostate cancer. Cancer Res (2001) 1.27
A randomized, controlled clinical trial of a treatment for shoulder pain. Phys Ther (1997) 1.27
Isolation of a gene encoding a novel member of the nuclear receptor superfamily from the critical region of Usher syndrome type IIa at 1q41. Genomics (1998) 1.25
Variable expression of CD3-zeta chain in tumor-infiltrating lymphocytes (TIL) derived from renal-cell carcinoma: relationship with TIL phenotype and function. Int J Cancer (1995) 1.25
TNIP1, SLC15A4, ETS1, RasGRP3 and IKZF1 are associated with clinical features of systemic lupus erythematosus in a Chinese Han population. Lupus (2010) 1.25
Tumor necrosis factor alpha expression produces increased blood-brain barrier permeability following temporary focal cerebral ischemia in mice. Brain Res Mol Brain Res (1999) 1.23
Infection of human primary renal epithelial cells with HIV-1 from children with HIV-associated nephropathy. Kidney Int (1998) 1.22
Association of race, age, menopausal status, and cerumen type with breast fluid secretion in nonlactating women, as determined by nepple aspiration. J Natl Cancer Inst (1975) 1.21
Bedside tracheostomy in the intensive care unit: a prospective randomized trial comparing open surgical tracheostomy with endoscopically guided percutaneous dilational tracheotomy. Laryngoscope (2001) 1.19
Proteolytic activity of blowfly larvae secretions in experimental burns. Surgery (1981) 1.19
Analysis of mechanisms regulating expression of the ver-1 gene, involved in aflatoxin biosynthesis. Appl Environ Microbiol (1997) 1.18
Molecular characterization of an Aspergillus parasiticus dehydrogenase gene, norA, located on the aflatoxin biosynthesis gene cluster. Appl Environ Microbiol (1996) 1.17
Circulating phospholipase A2 activity associated with sepsis and septic shock is indistinguishable from that associated with rheumatoid arthritis. Inflammation (1991) 1.16
The cAMP signaling pathway as a therapeutic target in lymphoid malignancies. Leuk Lymphoma (2000) 1.16
Perineural invasion and seminal vesicle involvement predict pelvic lymph node metastasis in men with localized carcinoma of the prostate. J Urol (1998) 1.16
The role of cyclooxygenase-2 in prostate cancer. Urology (2001) 1.16
Identification and chromosomal mapping of new human tyrosine kinase genes. Oncogene (1990) 1.15
Nanostructured polymer scaffolds for tissue engineering and regenerative medicine. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2010) 1.15
Exercise stress echocardiography for the study of the pulmonary circulation. Eur Respir J (2009) 1.15
Doppler echocardiographic diagnosis and follow-up of acquired pulmonary stenosis due to external cardiac compression. Cardiology (1995) 1.15
Glycemic response to wheat products: reduced response to pasta but no effect of fiber. Diabetes Care (1983) 1.15
The relationship between pre-pregnancy care and early pregnancy loss, major congenital anomaly or perinatal death in type I diabetes mellitus. BJOG (2007) 1.14